BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Luo X, Xu J, Yu J, Yi P. Shaping Immune Responses in the Tumor Microenvironment of Ovarian Cancer. Front Immunol 2021;12:692360. [PMID: 34248988 DOI: 10.3389/fimmu.2021.692360] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
Number Citing Articles
1 Porter RL, Matulonis UA. Checkpoint Blockade: Not Yet NINJA Status in Ovarian Cancer. J Clin Oncol 2021;39:3651-5. [PMID: 34529504 DOI: 10.1200/JCO.21.01886] [Reference Citation Analysis]
2 Wang K, Yang C, Li H, Liu X, Zheng M, Xuan Z, Mei Z, Wang H. Role of the Epigenetic Modifier JMJD6 in Tumor Development and Regulation of Immune Response. Front Immunol 2022;13:859893. [DOI: 10.3389/fimmu.2022.859893] [Reference Citation Analysis]
3 Liu J, Wang Y, Yuan S, Wei J, Bai J. Construction of an Immune Cell Infiltration Score to Evaluate the Prognosis and Therapeutic Efficacy of Ovarian Cancer Patients. Front Immunol 2021;12:751594. [PMID: 34745124 DOI: 10.3389/fimmu.2021.751594] [Reference Citation Analysis]
4 El Bairi K, Al Jarroudi O, Afqir S. Inexpensive Systemic Inflammatory Biomarkers in Ovarian Cancer: An Umbrella Systematic Review of 17 Prognostic Meta-Analyses. Front Oncol 2021;11:694821. [PMID: 34631526 DOI: 10.3389/fonc.2021.694821] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Wu W, Zhou S, Liu T, Liang D. Mitochondrial transcription factor B2 overexpression increases M2 macrophage infiltration via cytosolic mitochondrial DNA-stimulated Interleukin-6 secretion in ovarian cancer. Bioengineered 2022;13:12211-23. [PMID: 35577351 DOI: 10.1080/21655979.2022.2074615] [Reference Citation Analysis]